CDTX vs LYB · rev $1.3M vs P/E 21, rev $40.30B
Cidara Therapeutics Inc (CDTX) versus LyondellBasell Industries NV (LYB) — a side-by-side from cached financials, not a winner call.
Cidara Therapeutics Inc (CDTX) is a biotechnology company listed on US.
LyondellBasell Industries NV (LYB) is a specialty chemicals company listed on US.
Latest reported CDTX revenue for 2024-12-31 was $1.3M. Net income was -$169.8M. Revenue was down 94.5% from 2023-12-31 to 2024-12-31. CDTX currently screens at market cap $6.96B.
Latest reported LYB revenue for 2024-12-31 was $40.30B. Net income was $1.37B. Revenue was down 2.0% from 2023-12-31 to 2024-12-31. LYB currently screens at market cap $19.93B and trailing P/E 21.5.
CDTX currently screens at market cap $6.96B. LYB currently screens at market cap $19.93B and trailing P/E 21.5.
Not investment advice. Open the CDTX and LYB stock pages for the full models.
Not investment advice.